Skip to main content
. 2019 Feb 11;9(2):57. doi: 10.3390/biom9020057

Figure 1.

Figure 1

Level of understanding of biosimilars by the Russian physicians surveyed (n = 206). (A) Knowledge about biosimilars and reference products; (B) Familiarity with country regulations for biosimilars; (C) Attitude towards introduction of biosimilars in Russia. Data were extracted from questions 4, 5, and 7e of the questionnaire (see Survey Questionnaire 1).